These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26112646)

  • 1. Recombinant influenza virus carrying human adenovirus epitopes elicits protective immunity in mice.
    Yang P; Li T; Liu N; Gu H; Han L; Zhang P; Li Z; Wang Z; Zhang S; Wang X
    Antiviral Res; 2015 Sep; 121():145-51. PubMed ID: 26112646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bivalent vaccine platform based on ca influenza virus vaccine elicits protective immunity against human adenoviruses.
    Gu H; Gao Y; Zhou S; Sun F; Zhao Z; Wang K; Zhao L; Zhang P; Wang Z; Zhang S; Wang X; Yang P
    Antiviral Res; 2018 May; 153():78-84. PubMed ID: 29501624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
    Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
    Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice.
    Bian C; Liu S; Liu N; Zhang G; Xing L; Song Y; Duan Y; Gu H; Zhou Y; Zhang P; Li Z; Zhang K; Wang Z; Zhang S; Wang X; Yang P
    Antiviral Res; 2014 Apr; 104():110-7. PubMed ID: 24509239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing epitopes mapping of human adenovirus type 14 hexon.
    Ma Q; Tian X; Jiang Z; Huang J; Liu Q; Lu X; Luo Q; Zhou R
    Vaccine; 2015 Nov; 33(48):6659-65. PubMed ID: 26546264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions.
    Qiu H; Li X; Tian X; Zhou Z; Xing K; Li H; Tang N; Liu W; Bai P; Zhou R
    J Virol; 2012 Aug; 86(15):7964-75. PubMed ID: 22623776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach.
    Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA
    Virol J; 2015 Sep; 12():140. PubMed ID: 26362430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of neutralizing monoclonal antibodies against a conformational epitope of human adenovirus type 7 (HAdv-7) incorporated in capsid encoded in a HAdv-3-based vector.
    Liu M; Tian X; Li X; Zhou Z; Li C; Zhou R
    PLoS One; 2014; 9(7):e103058. PubMed ID: 25054273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon.
    Tian X; Qiu H; Zhou Z; Wang S; Fan Y; Li X; Chu R; Li H; Zhou R; Wang H
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Application of Neutralizing Epitopes of Human Adenovirus Type 55 Hexon Protein.
    Tian X; Ma Q; Jiang Z; Huang J; Liu Q; Lu X; Luo Q; Zhou R
    Viruses; 2015 Oct; 7(10):5632-42. PubMed ID: 26516903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector.
    Zhang Q; Su X; Seto D; Zheng BJ; Tian X; Sheng H; Li H; Wang Y; Zhou R
    Vaccine; 2009 Feb; 27(8):1145-53. PubMed ID: 19146906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-vectored type Asia1 foot-and-mouth disease virus (FMDV) capsid proteins as a vehicle to display a conserved, neutralising epitope of type O FMDV.
    Chai Z; Wang H; Zhou G; Yang D; Wang J; Yu L
    J Virol Methods; 2013 Mar; 188(1-2):175-82. PubMed ID: 22981982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope mapping and cross-reactivity analysis of the monoclonal antibodies against hexon protein of human adenovirus type 3.
    Qiu H; Zhou Z; Feng K; Tian X; Li X; Li H; Xing K; Chen J; Li C; Zhou R
    Virus Res; 2009 Dec; 146(1-2):58-65. PubMed ID: 19732803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and efficacy in mice of an adenovirus-based bicistronic rotavirus vaccine expressing NSP4 and VP7.
    Xie L; Yan M; Wang X; Ye J; Mi K; Yan S; Niu X; Li H; Sun M
    Virus Res; 2015 Dec; 210():298-307. PubMed ID: 26368053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant infectious bursal disease virus expressing Newcastle disease virus (NDV) neutralizing epitope confers partial protection against virulent NDV challenge in chickens.
    Li K; Gao L; Gao H; Qi X; Gao Y; Qin L; Wang Y; Wang X
    Antiviral Res; 2014 Jan; 101():1-11. PubMed ID: 24200519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55.
    Liu T; Zhou Z; Tian X; Liu W; Xu D; Fan Y; Liao J; Gu S; Li X; Zhou R
    Vaccine; 2018 Apr; 36(16):2199-2206. PubMed ID: 29548605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies.
    Pacesa M; Hendrickx R; Bieri M; Flatt JW; Greber UF; Hemmi S
    Virol J; 2017 Aug; 14(1):158. PubMed ID: 28821267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon.
    Haque E; Banik U; Monowar T; Anthony L; Adhikary AK
    PLoS One; 2018; 13(3):e0194516. PubMed ID: 29590206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel human monoclonal antibody potently neutralizes human adenovirus serotype 7 by primarily targeting the adenovirus hexon protein.
    Lu J; Wang R; Huang Y; Yu Y; Zhou X; Huang P; Yang Z
    Virology; 2020 Apr; 543():20-26. PubMed ID: 32056843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with the N-terminal region of the nonstructural protein NS1 promotes survival after challenge with lethal influenza A virus dose.
    Tamura M; Saikh KU; Kurane I; Ennis FA
    Viral Immunol; 1998; 11(3):131-5. PubMed ID: 9918404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.